The management team is responsible for developing the strategic direction for the company. It oversees daily operations and ensures the company’s ability to meet and exceed stakeholder expectations. You can read their resumes below.
Ulla Grove Krogsgaard Thomsen holds a M.Sc. in Pharmaceutical Sciences from 1992 and a Ph.D. in Structural and Analytical chemistry from 1996, both obtained at University of Copenhagen.
Dr. Thomsen joined Novo Nordisk Pharmatech A/S in 2021 as the CEO. Since 2019 she has been a member of the Bord of Directors. Dr. Thomsen joined Novo Nordisk A/S in 1997 where she initially headed up various scientific and leadership positions within Protein Engineering Research. For the last 12 years Dr. Thomsen has headed op Biopharmaceuticals API production in Product Supply.
Dr. Thomsen is a Danish National, born in 1968.
Bo Højriis Frandsen holds a Master of Science in Economics from Copenhagen University.
Mr. Frandsen started his career in Novo Nordisk A/S Corporate Finance in 2001 and has held several different management positions over the years. In 2012 he moved to Zurich to take up the position as Finance Director for Novo Nordisk International Operations. Prior to joining Novo Nordisk Pharmatech A/S, Mr. Frandsen came from the position as Finance & Operations Director for the Novo Nordisk sales affiliate in Brazil, where he had the responsibility for Finance, Supply Chain, Procurement, IT and Project Management Office.
Mr. Frandsen assumed the position of CFO on August 1, 2020, he is a Danish National, born in 1974.
Gernot Stadlmann holds a M.Sc. in Chemical Engineering and Economics from the Johannes Kepler University in Linz, Austria from 1999.
Mr. Stadlmann joined Novo Nordisk Pharmatech in May 2019 as global sales and marketing director heading the commercial functions and business development. Before joining Novo Nordisk Mr. Stadlmann spent 3 years in Singapore for another global company as sales director for Asia Pacific and held various positions within sales and management in the life science and pharmaceutical industry. He has almost 20 years of management experience.
Mr. Stadlmann is Austrian citizen, born in 1974.
Annette Behrens holds an MSc and a Ph.D. in Chemical Engineering from The Technical University of Denmark from 1993 and 1997 respectively.
Dr Behrens joined Novo Nordisk Pharmatech A/S in 2013 as Associate Manager for the Microanalysis Centre in R&D where she was heading the establishment of a quality management system for micro analysis testing. In 2015 she took up the role as Associate Manager for the Quality Assurance team and in April 2017 she became Director for Quality Assurance, Quality Control & Regulatory Affairs.
Dr Behrens joined Novo Nordisk A/S in 2002 where she held up various positions within Quality Control mainly within establishment of laboratories and management. Before joining Novo Nordisk A/S she had filled up different positions at Risø and DHI within quality control and statistical data analysis of food and environmental samples
Dr. Behrens is a Danish National, born in 1966.
John Boiesen holds a Master of Science in Forestry from University of Copenhagen.
Mr. Boiesen started his career at Novo Nordisk in 2005 as a Supply Chain Graduate and took his first leadership position in Shipping & Customer Service in 2007. Since 2007, John has held various leadership positions in Novo Nordisk A/S – Product Supply within supply chain, warehouse and business support.
Mr. Boiesen resumed the responsibility as Director of Manufacturing at Novo Nordisk Pharmatech A/S, Janaury 1. 2020.
Mr. Boiesen is a Danish national, born in 1974.
Kristoffer Laursen holds a M.Sc. in Process Analytical Technology from 2007 and a Ph.D. in Multivariate Data Analysis from 2011, both obtained at University of Copenhagen.
Dr. Laursen joined Novo Nordisk Pharmatech in 2017 as R&D Director where he is heading the development of chromatography resins and the Microanalysis Centre of Novo Nordisk Pharmatech. Dr. Laursen joined Novo Nordisk A/S in 2007 where he headed up various scientific and management positions within Diabetes API Manufacturing Development.
Dr. Laursen is a Danish National, born in 1980.
Jon Martin Winther holds a bachelor degree in Leadership & Land Warfare from the Royal Danish Military Academy (RDMA), as well as a Master in Business Development (MBD) from Copenhagen Business School (CBS), 2008 and 2021 respectively.
Mr. Winther joined Novo Nordisk Pharmatech A/S (NNPR) in 2017 as Associate Manager for the Microanalysis Centre in R&D, where he facilitated the strategy for digitalising planning and management for microanalysis testing and reporting. In 2020 he took up the role as Associate Manager for the Quality Assurance & Regulatory Affairs team, where he initiated the optimisation of the NNPR Management System (QMS) and launched the ‘QA Partner’ concept, focussing on stronger collaboration between line of business and QA. In March 2022 he became Director for Projects, IT and Optimisations (PIO).
Before joining Novo Nordisk Pharmatech A/S, Mr. Winther held various leadership positions in the Danish Armed Forces, including three tours of duty to Bosnia Herzegovina and Afghanistan. He ended his Army career wit the rank of Captain.
Mr. Winther is a Danish National, born in 1978.
Your message has been sent!
An error has occured
Please send us an email at firstname.lastname@example.org